|
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia
|
Oct 2023
|
International Journal of Hematology
|
aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic syndromes with ring sideroblasts
|
Oct 2023
|
Hematological Oncology
|
myelodysplastic syndromes (MDS)
|
|
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT
|
Oct 2023
|
Lancet Hematology
|
myelodysplastic syndromes (MDS)
|
|
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
|
Oct 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
Clinical decision‐making and treatment of myelodysplastic syndromes
|
Oct 2023
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy
|
Oct 2023
|
Annual Review of Pathology: Mechanisms of Disease
|
aplastic anemia
|
|
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
|
Oct 2023
|
Annals of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
|
Oct 2023
|
Leukemia
|
aplastic anemia
|
|
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
|
Oct 2023
|
Oncologist
|
myelodysplastic syndromes (MDS)
|
|
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
|
Oct 2023
|
Journal of Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
